author-photo

Laura K. Whited

University of Texas MD Anderson Cancer Center

10

Papers

11

Citations

Citation Trend

Filter By

Papers (6) Sort By

Journal Conference Others

Post-transplantation cyclophosphamide reduces the incidence of acute graft-versus-host disease in patients with acute myeloid leukemia/myelodysplastic syndromes who receive immune checkpoint inhibitors after allogeneic hematopoietic stem cell transplantation.

2021 Journal for ImmunoTherapy of Cancer
Show All
- Source
- Cite
- Save
Citations (2)
Cardiac Toxicity after Matched Allogeneic Hematopoietic Cell Transplantation in the Post-Transplant Cyclophosphamide Era.

2021 Blood Advances
Show All
- Source
- Cite
- Save
Citations (0)
Feasibility and Implementation of a Multimodal Supportive Care Program to Improve Outcomes in Older Patients Undergoing Allogeneic Stem Cell Transplantation.

2021
Show All
- Source
- Cite
- Save
Citations (0)
Enhanced Recovery Program in Older Patients Undergoing Allogeneic Stem Cell Transplantation (ER-SCT): First Year Outcomes

2020 Biology of Blood and Marrow Transplantation
Show All
- Source
- Cite
- Save
Citations (0)
Cardiac Toxicities after HLA-Matched Allogeneic Hematopoietic Cell Transplantation (Allo-HCT): Post-Transplant Cyclophosphamide (PTCy) Is Not Associated with Higher Incidence of Cardiotoxicity

2020 Biology of Blood and Marrow Transplantation
Show All
- Source
- Cite
- Save
Citations (2)
Incidence of Viral and Fungal Infectious Complications after utilization of alternative donor sources in hematopoietic cell transplantation (HCT).

2020 Pharmacotherapy
Show All
- Source
- Cite
- Save
Citations (1)